News

What does the Moody's rating downgrade mean for the economy?
The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...
Regeneron to rescue 23andMe from bankruptcy in $256 million deal — but who really owns your genetic data now and what happens to your DNA privacy?
Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...
Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ...
Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ... The move raises privacy concerns as the drugmaker takes control of the genetic ...
Energy investor Five Point targets $2 billion from Northwind pipelines sale, sources say
The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure ...
Rolling Out9h
The fall of 23andMe and what it means for your DNA
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
US stocks end higher, shrugging off Moody’s downgrade
The Dow Jones Industrial Average finished up 0.3 per cent at 42,792.07. Read more at straitstimes.com. Read more at ...
Investing Snacks25m
Mufg Makes a Micro Move, but Regeneron Feels It
Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...
FTSE and US stocks slump, bond yields rise after Moody's downgrade
The FTSE 100 , US markets and European stocks floundered on Monday, despite a new deal struck between the EU and UK, as ...
The Wall Street Transcript5h
Contrarian Investing in Biotechs and Medical Device Stocks
Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...
Regeneron Pharmaceuticals to buy 23andMe for $256M
Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March ...
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the ...
23andMe sold to biotech company Regeneron for $256 million
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...